Patent ID: 7658938

Claim:
A solid oral dosage form which is effective in delivering a drug and an enhancer, each as defined below, to an intestine and which comprises a pharmaceutical composition consisting of: (A) a therapeutically effective amount of a bisphosphonate drug in the form of crystalline and/or amorphous particles; (B) one or more absorption enhancers, each of which: (i) is a solid at room temperature; (ii) is a salt of a medium chain fatty acid having a carbon length of from 8 to 14 carbon atoms in particulate form; and (iii) is present in the dosage form in a therapeutically effective amount and such that the ratio of the drug to the one or more absorption enhancers is 1:100,000 to 10:1; and (C) one or more excipients selected from the group consisting of rate-controlling polymeric materials, diluents, lubricants, disintegrants, plasticizers, anti-tack agents, opacifying agents, pigments, and flavorings.